Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.03 | N/A |
PEG Ratio (TTM) | 0.02 | N/A |
P/S Ratio (TTM) | 0.68 | N/A |
P/B Ratio (TTM) | 0.07 | N/A |
P/FCF Ratio (TTM) | -0.47 | N/A |
Price to 5YR AVG Earnings Ratio | 0.00 | N/A |
Price to 5YR AVG FCF Ratio | -1.01 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -140.78% | N/A |
ROE (TTM) | -386.16% | N/A |
Net Profit Margin (TTM) | -184.32% | N/A |
ROIC 5YR AVG | -1,296.67% | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 12.30% | -33.56% | -302.96% |
Revenue | 319.99% | -60.06% | -36.04% |
Net Income | -42.85% | -146.37% | -95.90% |
Cash Flow | -16.63% | -318.99% | -199.94% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.40 | N/A |
Quick Ratio (TTM) | 1.40 | N/A |
D/E Ratio (TTM) | 0.04 | N/A |
Interest Coverage (TTM) | -6.17 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.12 | N/A |
Shares Outstanding Growth 5YR AVG | 1,335.02% | N/A |